Delta-Fly Pharma, Inc. focuses on innovative drug development, emphasizing a modular approach to create effective therapeutic solutions. The company is dedicated to advancing its research and development pipeline, which includes a variety of products aimed at addressing unmet medical needs. Their strategy encompasses not only the development of proprietary drugs but also the exploration of licensing opportunities to enhance their market presence and collaborative efforts in the pharmaceutical industry.

The company employs cutting-edge scientific methodologies to drive its research initiatives. Delta-Fly Pharma is committed to leveraging advanced technologies in drug formulation and delivery, ensuring that their products are both effective and safe for patients. Their emphasis on rigorous scientific research is reflected in their presentations and publications, which aim to share knowledge and foster collaboration within the scientific community. Overall, Delta-Fly Pharma's focus on modular drug development and innovative research positions it as a forward-thinking entity in the pharmaceutical landscape.

Japan

Delta-Fly Pharma - We focus not only on cancer itself but on the whole conditions of cancer patients, and aim to deliver medicines that are recommendable for cancer patients and their families.

We develop medicines with an original concept called Module Drug Development.

Module Drug Development is the assembly of various active ingredients into novel anticancer agents. With this approach and application of drug delivery technologies and knowledge about dosage and administration, drugs with a good balance of safety and efficacy can be developed in a short period of tim

Delta-Fly Pharma

Company Details